1. Home
  2. ATLX vs KRRO Comparison

ATLX vs KRRO Comparison

Compare ATLX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$4.22

Market Cap

125.6M

Sector

Industrials

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.05

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
KRRO
Founded
2011
2014
Country
Brazil
United States
Employees
64
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
150.0M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
ATLX
KRRO
Price
$4.22
$13.05
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$12.00
$34.80
AVG Volume (30 Days)
1.0M
114.0K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
47.08
N/A
EPS
N/A
N/A
Revenue
$92,491.00
$6,392,000.00
Revenue This Year
$64,564.67
N/A
Revenue Next Year
$785.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$3.60
$5.20
52 Week High
$8.25
$55.89

Technical Indicators

Market Signals
Indicator
ATLX
KRRO
Relative Strength Index (RSI) 40.41 58.48
Support Level $3.97 $9.51
Resistance Level $5.12 $14.52
Average True Range (ATR) 0.35 0.95
MACD -0.10 0.32
Stochastic Oscillator 6.91 85.42

Price Performance

Historical Comparison
ATLX
KRRO

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: